Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 2.10 is 44% below its 5-year average of 3.78, around the middle of its 5-year range (-0.95–8.12).
As of the fiscal period ended Sunday, December 28, 2025. 6.46% below its 12-month average of 2.25.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
2.10
EARNINGS PER SHARE (EPS) AVG TTM
2.25
EARNINGS PER SHARE (EPS) AVG 3Y
2.01
EARNINGS PER SHARE (EPS) AVG 5Y
3.78
EARNINGS PER SHARE (EPS) AVG 10Y
2.91
EARNINGS PER SHARE (EPS) AVG 15Y
1.93
EARNINGS PER SHARE (EPS) AVG 20Y
1.47
CURRENT VS TTM AVG
-6.46%
CURRENT VS 3Y AVG
+4.32%
CURRENT VS 5Y AVG
-44.49%
CURRENT VS 10Y AVG
-27.73%
CURRENT VS 15Y AVG
+8.95%
CURRENT VS 20Y AVG
+42.56%
Revvity, Inc.
Market Cap
$12.55B
Earnings Per Share (EPS)
2.10
TTM Avg
2.25
3Y Avg
2.01
5Y Avg
3.78
Market Cap
$12.11B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$13.51B
Earnings Per Share (EPS)
-2.04
TTM Avg
-1.51
3Y Avg
-0.65
5Y Avg
0.36
Market Cap
$11.45B
Earnings Per Share (EPS)
4.30
TTM Avg
4.74
3Y Avg
3.13
5Y Avg
2.14
Market Cap
$11.29B
Earnings Per Share (EPS)
0.69
TTM Avg
0.77
3Y Avg
1.27
5Y Avg
1.25
Market Cap
$11.20B
Earnings Per Share (EPS)
-3.76
TTM Avg
-1.35
3Y Avg
4.03
5Y Avg
5.21
Market Cap
$14.10B
Earnings Per Share (EPS)
1.18
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
11.98
Market Cap
$10.37B
Earnings Per Share (EPS)
-7.29
TTM Avg
-6.79
3Y Avg
-1.56
5Y Avg
-0.26
Market Cap
$14.80B
Earnings Per Share (EPS)
8.17
TTM Avg
5.85
3Y Avg
6.82
5Y Avg
7.06
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $12.55B | 2.10 | 2.25 | 2.01 | 3.78 |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 5.76 | 5.64 | 5.43 | 9.01 |
| Baxter International Inc. (BAX)vs › | $13.51B | -2.04 | -1.51 | -0.65 | 0.36 |
| Insulet Corp. (PODD)vs › | $11.45B | 4.30 | 4.74 | 3.13 | 2.14 |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 0.69 | 0.77 | 1.27 | 1.25 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | -3.76 | -1.35 | 4.03 | 5.21 |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 1.18 | 1.92 | 1.82 | 11.98 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.29 | -6.79 | -1.56 | -0.26 |
| Solventum Corporation (SOLV)vs › | $14.80B | 8.17 | 5.85 | 6.82 | 7.06 |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 0.19 | 14.72 | 15.46 | 14.11 |
Trailing EPS (TTM)
$2.10
Forward EPS (Est.)
$5.24
P/E Ratio
53.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-28 | 2.08 |
| 2024-12-29 | 2.41 |
| 2023-12-31 | -0.95 |
| 2022-12-31 | 4.51 |
| 2021-12-31 | 8.12 |
| 2020-12-31 | 6.53 |
| 2019-12-31 | 2.05 |
| 2018-12-31 | 2.16 |
| 2017-12-31 | 1.03 |
| 2016-12-31 | 2.13 |
| 2015-12-31 | 1.89 |
| 2014-12-31 | 1.40 |
| 2013-12-31 | 1.50 |
| 2012-12-31 | 0.60 |
| 2011-12-31 | 0.01 |
| 2010-12-31 | 3.28 |
| 2009-12-31 | 0.74 |
| 2008-12-31 | 1.07 |
| 2007-12-31 | 1.12 |
| 2006-12-31 | 0.94 |
| 2005-12-31 | 0.63 |
| 2004-12-31 | 0.60 |
| 2003-12-31 | 0.42 |
| 2002-12-31 | -0.03 |
| 2001-12-31 | -0.01 |
| 2000-12-31 | 0.92 |
| 1999-12-31 | 0.31 |
| 1998-12-31 | 1.13 |
| 1997-12-31 | 0.37 |
| 1996-12-31 | 0.64 |
Reported annual fiscal-period values; no daily interpolation.
